Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
002675.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -9.56 | 0.29 | 2.41 | -2.15 |
| FCF Yield | 0.28% | 0.55% | 0.37% | 0.19% |
| EV / EBITDA | 82.18 | 77.79 | 119.69 | 217.03 |
| Quality | ||||
| ROIC | 0.97% | 0.70% | 0.23% | -0.15% |
| Gross Margin | 58.02% | 47.43% | 45.34% | 51.35% |
| Cash Conversion Ratio | 1.23 | – | 4.61 | 6.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.08% | -7.71% | -6.46% | -7.14% |
| Free Cash Flow Growth | -46.45% | 61.66% | 109.93% | -75.63% |
| Safety | ||||
| Net Debt / EBITDA | 1.53 | 0.15 | 0.33 | 0.62 |
| Interest Coverage | 1.27 | 0.00 | 1.27 | 0.17 |
| Efficiency | ||||
| Inventory Turnover | 0.44 | 0.58 | 0.62 | 0.53 |
| Cash Conversion Cycle | 275.72 | 130.08 | 129.40 | 135.99 |